Correction to “Biomimetic Liposomal Nanoplatinum for Targeted Cancer Chemophototherapy”
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsNanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery
Xue‐Liang Liu, Xiao Dong, Si‐Cong Yang, Xing Lai, Hai‐Jun Liu, Yuhao Gao, Hai‐Yi Feng, Mao‐Hua Zhu, Yihang Yuan, Qin Lu, Jonathan F. Lovell, Hong‐Zhuan Chen*, Chao Fang*. Biomimetic Liposomal Nanoplatinum for Targeted Cancer Chemophototherapy. Adv Sci, 2021, 8, 2003679.
The image of the saline group (untreated control) in Figure 6J was inadvertently derived from the MLipo (empty) group (a drug‐free control). The corrected “Saline” panel for Figure 6J is presented below.
Figure 6J. H&E staining of the tumor paraffin section. Necrotic areas are outlined with dotted lines.
The authors apologize for this error and for the inconvenience it may have caused.